Immunotherapy advances in pleural mesothelioma
Therapeutic Advances in Medical Oncology · 2026-02 · 18
DOI: 10.1177/17588359261420028 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Therapeutic Advances in Medical Oncology, online erschienen am 13.02.2026. Verfasst von Annie L Zhang und 1 weiteren Autor:innen. Beteiligte Einrichtung: University Hospitals Seidman Cancer Center, Cleveland, OH, USA. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Mesothelioma is a rare cancer that carries a poor prognosis. This malignancy has had few therapeutic advances prior to the introduction of immune checkpoint inhibitors. Immunotherapy is now a cornerstone of first-line treatment for pleural mesothelioma and has been shown to provide clinical benefit for relapsed or refractory patients treated with prior chemotherapy. This review article will discuss key immunotherapy trials in the scientific literature, along with challenges in the application of this therapy. We will also discuss future areas of immunotherapy research in the treatment of mesothelioma.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- University Hospitals Seidman Cancer Center, Cleveland, OH, USA.
- Department of Medicine, Division of Oncology, Case Western Reserve University, Cleveland, OH, USA.
- University Hospitals Seidman Cancer Center, 11100 Euclid Avenue, Cleveland, OH 44106, USA.
ORCID-Profile: Annie L Zhang, Melinda L Hsu
Zitieren
APA
Zhang, A. L., & Hsu, M. L. (2026). Immunotherapy advances in pleural mesothelioma. Therapeutic Advances in Medical Oncology, 18. https://doi.org/10.1177/17588359261420028
Vancouver
Zhang AL, Hsu ML. Immunotherapy advances in pleural mesothelioma. Therapeutic Advances in Medical Oncology. 2026;18. doi:10.1177/17588359261420028
BibTeX
@article{Zhang2026,
author = {Zhang, Annie L and Hsu, Melinda L},
title = {Immunotherapy advances in pleural mesothelioma},
journal = {Therapeutic Advances in Medical Oncology},
year = {2026},
volume = {18},
doi = {10.1177/17588359261420028}
}
EUVIMED